WHO ICTRP trial
A Phase III, Multicenter, 52-Week, Randomized, Double-Blind, Placebo-Controlled…
EUCTR2004-004617-42-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-004617-42-GB |
|---|---|
| Public title | A Phase III, Multicenter, 52-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Clinical Efficacy and Safety of ICA-17043 with or without Hydroxyurea Therapy in Patients with Sickle Cell Disease who have had = 2 Acute Sickle-Related Painful Crises within the Preceding 12 Months. - A Stratified Sickle Event Randomised Trial - ASSERT |
| Scientific title | A Phase III, Multicenter, 52-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Clinical Efficacy and Safety of ICA-17043 with or without Hydroxyurea Therapy in Patients with Sickle Cell Disease who have had = 2 Acute Sickle-Related Painful Crises within the Preceding 12 Months. - A… |
| Primary sponsor | Icagen Inc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Therapeutic exploratory (Phase II): Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): |
| Countries | United Kingdom |
| Conditions | Sickle Cell Disease |
| Interventions | Product Name: Bis (4-fluorophenyl)phenyl acetamide Product Code: ICA-17043 Pharmaceutical Form: Tablet CAS Number: 289656-45-7 Current Sponsor code: ICA-17043 Other descriptive name: Bis(4-fluorophenyl)phenyl acetamide Concentration unit… |
| Registration date | Nov 5, 2005 |
| Target size | 328 |
| Secondary IDs | ICA-17043-10 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: